Physician profile
Barbara Noel
NPI 1346265840
$729.32
in general payments reported to CMS, 2019-2025
14 companies · $71.77 in 2025
The $71.77 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $257 · 2021: $85.56 · 2022: $32.90 · 2023: $55.29 · 2024: $123 · 2025: $71.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $231 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.88 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $184.15 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $130.52 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $122.12 | 2020 | |
| Hologic Sales and Service, LLC | $66.55 | 2023-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $33.81 | 2023-2024 | Veozah |
| Exeltis, USA INC. | $31.54 | 2020 | |
| Bard Peripheral Vascular, INC. | $30.00 | 2020 | |
| Avion Pharmaceuticals | $29.45 | 2019-2021 | |
| Lupin INC. | $23.00 | 2020 | |
| Therapeuticsmd, INC. | $19.53 | 2019 | |
| Pfizer INC. | $19.27 | 2023 | |
| Merck Sharp & Dohme LLC | $14.08 | 2019 | |
| Dysis Medical, INC. | $13.86 | 2022 | |
| Allergan, INC. | $11.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Noel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.